Product
18F-DOPA
5 clinical trials
15 indications
Indication
Congenital HyperinsulinismIndication
NeuroblastomaIndication
Parkinson's diseaseIndication
Lewy Body DiseaseIndication
Neuroendocrine TumorsIndication
Brain TumorIndication
Beckwith-Wiedemann SyndromeIndication
InsulinomaIndication
Hepatitis CIndication
Hepatitis BIndication
Parkinson's DiseaseIndication
Multiple System AtrophyIndication
Autonomic FailureIndication
Adrenocorticotropic hormoneIndication
Cushing's syndromeClinical trial
Expanded Access Use of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic HypoglycemiaStatus:
Clinical trial
Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) in Research of the Association Between HCV Infection and Parkinson's Disease.Status: , Estimated PCD: 2023-05-31
Clinical trial
Clinical Laboratory Evaluation of Chronic Autonomic FailureStatus: Recruiting, Estimated PCD: 2028-12-31
Clinical trial
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing SyndromeStatus: Recruiting, Estimated PCD: 2030-12-31